- Page 4: Yi-Wei Tang Charles W. Stratton Adv
- Page 8: Contributors Jaber Aslanzadeh Divis
- Page 12: Contributors vii David J. Kelvin De
- Page 16: Contributors ix David Zhang Molecul
- Page 20: xii Preface advantages and disadvan
- Page 24: xiv Contents 11 PCR and Its Variati
- Page 28: Part I Techniques
- Page 32: 4 X.Y.Han and microbial factors det
- Page 36: 6 X.Y.Han TABLE 1.1. Commercial con
- Page 40: 8 X.Y.Han However, the two CMBCSs d
- Page 44: 10 X. Y. Han Reimer, L. G., Wilson,
- Page 48: 12 S. Wang and X. Zheng therapy wit
- Page 52:
14 S. Wang and X. Zheng of H. pylor
- Page 56:
16 S. Wang and X. Zheng A further m
- Page 60:
18 S. Wang and X. Zheng tubes for G
- Page 64:
20 S. Wang and X. Zheng Graham, D.
- Page 68:
22 S. Wang and X. Zheng two test me
- Page 72:
24 S. Campbell and M. L. Landry Pri
- Page 76:
26 S. Campbell and M. L. Landry opp
- Page 80:
28 S. Campbell and M. L. Landry dir
- Page 84:
TABLE 3.1. Characteristics of the t
- Page 88:
TABLE 3.2. Application of technique
- Page 92:
TABLE 3.2 (Continued) Pathogen Meth
- Page 96:
TABLE 3.2 (Continued) Pathogen Meth
- Page 100:
38 S. Campbell and M. L. Landry Rap
- Page 104:
40 S. Campbell and M. L. Landry Ger
- Page 108:
4 Advanced Antibody Detection YUN F
- Page 112:
44 Y. F. Wang grouped into several
- Page 116:
46 Y. F. Wang variety of substrates
- Page 120:
48 Y. F. Wang One reason accounting
- Page 124:
50 Y. F. Wang by a carbodiimide con
- Page 128:
52 Y. F. Wang TABLE 4.2. Type of co
- Page 132:
54 Y. F. Wang small-volume samples
- Page 136:
56 Y. F. Wang Multiplexed Bead Assa
- Page 140:
58 Y. F. Wang the reliability of th
- Page 144:
60 Y. F. Wang Hemmila, I., Dakubu,
- Page 148:
62 Y. F. Wang (2002). Specific, sen
- Page 152:
64 C. Qi, C. W. Stratton, and X. Zh
- Page 156:
66 C. Qi, C. W. Stratton, and X. Zh
- Page 160:
68 C. Qi, C. W. Stratton, and X. Zh
- Page 164:
70 C. Qi, C. W. Stratton, and X. Zh
- Page 168:
72 C. Qi, C. W. Stratton, and X. Zh
- Page 172:
74 C. Qi, C. W. Stratton, and X. Zh
- Page 176:
76 C. Qi, C. W. Stratton, and X. Zh
- Page 180:
78 C. Qi, C. W. Stratton, and X. Zh
- Page 184:
80 C. Qi, C. W. Stratton, and X. Zh
- Page 188:
82 C. Qi, C. W. Stratton, and X. Zh
- Page 192:
6 Biochemical Profile-Based Microbi
- Page 196:
86 J. Aslanzadeh + beta hemolytic +
- Page 200:
88 J. Aslanzadeh Gram Negative Cocc
- Page 204:
90 J. Aslanzadeh Preliminary Identi
- Page 208:
92 J. Aslanzadeh tryptophane result
- Page 212:
94 J. Aslanzadeh β-naphthylamine p
- Page 216:
96 J. Aslanzadeh Reading the test b
- Page 220:
98 J. Aslanzadeh TABLE 6.1. Commonl
- Page 224:
100 J. Aslanzadeh Do not incubate t
- Page 228:
102 J. Aslanzadeh Using a sterile i
- Page 232:
104 J. Aslanzadeh Voges-Proskaure (
- Page 236:
106 J. Aslanzadeh The strip is exam
- Page 240:
108 J. Aslanzadeh ferrous sulfate i
- Page 244:
110 J. Aslanzadeh TABLE 6.2. Commer
- Page 248:
112 J. Aslanzadeh substrates. It is
- Page 252:
114 J. Aslanzadeh The reagents will
- Page 256:
116 J. Aslanzadeh Killian, M. (1974
- Page 260:
118 D. Dare Furthermore, the amount
- Page 264:
120 D. Dare be required. Currently,
- Page 268:
122 D. Dare TABLE 7.1. Comparison o
- Page 272:
124 D. Dare Search results Combined
- Page 276:
126 D. Dare (a) No. genera 4123 No.
- Page 280:
128 D. Dare that similarity of the
- Page 284:
130 D. Dare Dare, D., Sutton, H., K
- Page 288:
132 D. Dare McKenna, T., Lunt, M.,
- Page 292:
8 Probe-Based Microbial Detection a
- Page 296:
136 T. Hong Hybridization and Detec
- Page 300:
138 T. Hong Candida species can det
- Page 304:
140 T. Hong and 100%, respectively.
- Page 308:
142 T. Hong Wagner, M., Schmid, M.,
- Page 312:
144 F. Wu and P. Della-Latta migrat
- Page 316:
146 F. Wu and P. Della-Latta TABLE
- Page 320:
148 F. Wu and P. Della-Latta DNA d
- Page 324:
150 F. Wu and P. Della-Latta TABLE
- Page 328:
152 F. Wu and P. Della-Latta λ 1 2
- Page 332:
154 F. Wu and P. Della-Latta Summar
- Page 336:
156 F. Wu and P. Della-Latta pneumo
- Page 340:
10 In Vitro Nucleic Acid Amplificat
- Page 344:
160 H. Li and Y-W. Tang of these me
- Page 348:
162 H. Li and Y-W. Tang Currently,
- Page 352:
164 H. Li and Y-W. Tang La Rocco, M
- Page 356:
11 PCR and Its Variations MICHAEL L
- Page 360:
168 M. Loeffelholz and H. Deng to o
- Page 364:
170 M. Loeffelholz and H. Deng FIGU
- Page 368:
172 M. Loeffelholz and H. Deng be i
- Page 372:
174 M. Loeffelholz and H. Deng the
- Page 376:
176 M. Loeffelholz and H. Deng RT-P
- Page 380:
178 M. Loeffelholz and H. Deng Dete
- Page 384:
180 M. Loeffelholz and H. Deng buff
- Page 388:
182 M. Loeffelholz and H. Deng Grat
- Page 392:
12 Non-Polymerase Chain Reaction Me
- Page 396:
186 M.L. Pendrak and S.S. Yan TMA (
- Page 400:
188 M.L. Pendrak and S.S. Yan dsDNA
- Page 404:
190 M.L. Pendrak and S.S. Yan (van
- Page 408:
192 M.L. Pendrak and S.S. Yan ampli
- Page 412:
194 M.L. Pendrak and S.S. Yan FIGUR
- Page 416:
196 M.L. Pendrak and S.S. Yan RCA m
- Page 420:
198 M.L. Pendrak and S.S. Yan FIGUR
- Page 424:
200 M.L. Pendrak and S.S. Yan FIGUR
- Page 428:
202 M.L. Pendrak and S.S. Yan TABLE
- Page 432:
204 M.L. Pendrak and S.S. Yan of hu
- Page 436:
206 M.L. Pendrak and S.S. Yan Kwoh,
- Page 440:
208 M.L. Pendrak and S.S. Yan Smirn
- Page 444:
13 Recent Advances in Probe Amplifi
- Page 448:
212 D. Zhang et al. TABLE 13.1. Com
- Page 452:
214 D. Zhang et al. scanner after h
- Page 456:
216 D. Zhang et al. FIGURE 13.3. Sc
- Page 460:
218 D. Zhang et al. FIGURE 13.4. Sc
- Page 464:
220 D. Zhang et al. A. B. Invasive
- Page 468:
222 D. Zhang et al. FIGURE 13.6. Pr
- Page 472:
224 D. Zhang et al. The mecA probe
- Page 476:
226 D. Zhang et al. Landegren, U.,
- Page 480:
14 Signal Amplification Techniques:
- Page 484:
230 Y. F. Wang Virus (3)* (2) (4)*
- Page 488:
232 Y. F. Wang 1. Denaturation 2. H
- Page 492:
234 Y. F. Wang Application of the T
- Page 496:
236 Y. F. Wang specimen. A study (K
- Page 500:
238 Y. F. Wang amplification techno
- Page 504:
240 Y. F. Wang Cuzick, J., Szarewsk
- Page 508:
242 Y. F. Wang Qian, X., & Lloyd, R
- Page 512:
244 R. P. Podzorski, M. Loeffelholz
- Page 516:
246 R. P. Podzorski, M. Loeffelholz
- Page 520:
248 R. P. Podzorski, M. Loeffelholz
- Page 524:
250 R. P. Podzorski, M. Loeffelholz
- Page 528:
252 R. P. Podzorski, M. Loeffelholz
- Page 532:
254 R. P. Podzorski, M. Loeffelholz
- Page 536:
256 R. P. Podzorski, M. Loeffelholz
- Page 540:
258 R. P. Podzorski, M. Loeffelholz
- Page 544:
260 R. P. Podzorski, M. Loeffelholz
- Page 548:
262 R. P. Podzorski, M. Loeffelholz
- Page 552:
16 Direct Nucleotide Sequencing for
- Page 556:
266 Tao Hong approximately 10 min (
- Page 560:
268 Tao Hong frequently caused prob
- Page 564:
270 Tao Hong for the use of the 16S
- Page 568:
272 Tao Hong of MRSA. The coagulase
- Page 572:
274 Tao Hong Gürtler, V., & Barrie
- Page 576:
17 Microarray-Based Microbial Ident
- Page 580:
278 T.J. Gentry and J. Zhou These a
- Page 584:
280 T.J. Gentry and J. Zhou the des
- Page 588:
282 T.J. Gentry and J. Zhou Communi
- Page 592:
284 T.J. Gentry and J. Zhou PCR-bas
- Page 596:
286 T.J. Gentry and J. Zhou Althoug
- Page 600:
288 T.J. Gentry and J. Zhou Korczak
- Page 604:
290 T.J. Gentry and J. Zhou Willse,
- Page 608:
292 X. Qin allow real-time monitori
- Page 612:
294 X. Qin which the observed fluor
- Page 616:
296 X. Qin that there would be no G
- Page 620:
298 X. Qin 2005). Furthermore, the
- Page 624:
300 X. Qin Cattoli, G., Drago, A.,
- Page 628:
302 X. Qin Kostrikis, L.G., Touloum
- Page 632:
304 X. Qin Ririe, K.M., Rasmussen,
- Page 636:
19 Amplification Product Inactivati
- Page 640:
308 S. Sefers and Y-W. Tang Most de
- Page 644:
310 S. Sefers and Y-W. Tang UNG Pro
- Page 648:
312 S. Sefers and Y-W. Tang 4' Psor
- Page 652:
314 S. Sefers and Y-W. Tang Isopsor
- Page 656:
316 S. Sefers and Y-W. Tang used is
- Page 660:
318 S. Sefers and Y-W. Tang Conclus
- Page 664:
Part II Applications
- Page 668:
324 X.Y. Han TABLE 20.1. The number
- Page 672:
326 X.Y. Han Homology Search and Re
- Page 676:
328 X.Y. Han TABLE 20.2. Examples o
- Page 680:
330 X.Y. Han Conclusion In summary,
- Page 684:
332 X.Y. Han Shimizu, T., Ohtani, K
- Page 688:
TABLE 21.1. Licensed / Approved Cli
- Page 692:
TABLE 21.1. (Continued) Tradename(s
- Page 696:
TABLE 21.1. (Continued) Tradename(s
- Page 700:
340 Y. Hu and I. Hirshfield gel ele
- Page 704:
342 Y. Hu and I. Hirshfield Since 1
- Page 708:
344 Y. Hu and I. Hirshfield they ar
- Page 712:
346 Y. Hu and I. Hirshfield Antibod
- Page 716:
348 Y. Hu and I. Hirshfield all ove
- Page 720:
350 Y. Hu and I. Hirshfield chances
- Page 724:
352 Y. Hu and I. Hirshfield Tang, Y
- Page 728:
354 A. C. T. Lo and K. M. Kam in tu
- Page 732:
356 A. C. T. Lo and K. M. Kam is no
- Page 736:
358 A. C. T. Lo and K. M. Kam stabl
- Page 740:
360 A. C. T. Lo and K. M. Kam Stran
- Page 744:
362 A. C. T. Lo and K. M. Kam organ
- Page 748:
364 A. C. T. Lo and K. M. Kam probe
- Page 752:
366 A. C. T. Lo and K. M. Kam major
- Page 756:
368 A. C. T. Lo and K. M. Kam Molec
- Page 760:
370 A. C. T. Lo and K. M. Kam a sec
- Page 764:
372 A. C. T. Lo and K. M. Kam cervi
- Page 768:
374 A. C. T. Lo and K. M. Kam E6 an
- Page 772:
376 A. C. T. Lo and K. M. Kam M. (2
- Page 776:
378 A. C. T. Lo and K. M. Kam Hippe
- Page 780:
380 A. C. T. Lo and K. M. Kam Larse
- Page 784:
382 A. C. T. Lo and K. M. Kam Nobbe
- Page 788:
384 A. C. T. Lo and K. M. Kam chlam
- Page 792:
386 A. C. T. Lo and K. M. Kam ureal
- Page 796:
388 A. Kilic and W. Drake Lipids wi
- Page 800:
390 A. Kilic and W. Drake America,
- Page 804:
392 A. Kilic and W. Drake MTB from
- Page 808:
394 A. Kilic and W. Drake with anti
- Page 812:
396 A. Kilic and W. Drake Molecular
- Page 816:
398 A. Kilic and W. Drake and monit
- Page 820:
400 A. Kilic and W. Drake system; t
- Page 824:
402 A. Kilic and W. Drake transillu
- Page 828:
404 A. Kilic and W. Drake Real-Time
- Page 832:
406 A. Kilic and W. Drake Caws, M.,
- Page 836:
408 A. Kilic and W. Drake Marttila,
- Page 840:
410 A. Kilic and W. Drake Torres, M
- Page 844:
412 P. Francois and J. Schrenzel an
- Page 848:
414 P. Francois and J. Schrenzel th
- Page 852:
416 P. Francois and J. Schrenzel A
- Page 856:
418 P. Francois and J. Schrenzel St
- Page 860:
420 P. Francois and J. Schrenzel Ac
- Page 864:
422 P. Francois and J. Schrenzel or
- Page 868:
424 P. Francois and J. Schrenzel Lo
- Page 872:
426 P. Francois and J. Schrenzel Va
- Page 876:
428 D. Ernst et al. several microme
- Page 880:
430 D. Ernst et al. reanalysis to d
- Page 884:
432 D. Ernst et al. Neisseria menin
- Page 888:
434 D. Ernst et al. A. B. SEB-beads
- Page 892:
436 D. Ernst et al. IL-6, IL-8, and
- Page 896:
pg/ml 120 100 80 60 40 20 0 120 100
- Page 900:
440 D. Ernst et al. Although interf
- Page 904:
442 D. Ernst et al. Lal, G., Balmer
- Page 908:
26 Molecular Strain Typing Using Re
- Page 912:
446 S. R. Frye and M. Healy FIGURE
- Page 916:
448 S. R. Frye and M. Healy Automat
- Page 920:
450 S. R. Frye and M. Healy TABLE 2
- Page 924:
452 S. R. Frye and M. Healy Noncomm
- Page 928:
454 S. R. Frye and M. Healy 2001).
- Page 932:
456 S. R. Frye and M. Healy (Stempe
- Page 936:
458 S. R. Frye and M. Healy isolate
- Page 940:
460 S. R. Frye and M. Healy molecul
- Page 944:
462 S. R. Frye and M. Healy Boerlin
- Page 948:
464 S. R. Frye and M. Healy Fey, P.
- Page 952:
466 S. R. Frye and M. Healy Kwara,
- Page 956:
468 S. R. Frye and M. Healy Pfaller
- Page 960:
470 S. R. Frye and M. Healy Tang, Y
- Page 964:
27 Molecular Differential Diagnoses
- Page 968:
474 J. Han The technology advanceme
- Page 972:
476 J. Han Targets Optimal Conditio
- Page 976:
478 J. Han TABLE 27.1. Comparison o
- Page 980:
480 J. Han TABLE 27.3. Comparison o
- Page 984:
482 J. Han suspension hybridization
- Page 988:
484 J. Han fluorescent dye is remov
- Page 992:
486 J. Han TABLE 27.5. List of path
- Page 996:
TABLE 27.8. Detection results of th
- Page 1000:
490 J. Han common in HAI. In additi
- Page 1004:
492 J. Han TABLE 27.12. Detection r
- Page 1008:
494 J. Han TABLE 27.14. List of pat
- Page 1012:
496 J. Han TABLE 27.18. Detectable
- Page 1016:
TABLE 27.20. List of gene targets i
- Page 1020:
500 J. Han Benefits and Impact: Del
- Page 1024:
502 J. Han significantly increasing
- Page 1028:
504 J. Han Hindiyeh, M., Hillyard D
- Page 1032:
506 E. M. Marlowe and D. M. Wolk Al
- Page 1036:
TABLE 28.1. Automated specimen proc
- Page 1040:
510 E. M. Marlowe and D. M. Wolk Au
- Page 1044:
512 E. M. Marlowe and D. M. Wolk La
- Page 1048:
514 E. M. Marlowe and D. M. Wolk me
- Page 1052:
516 E. M. Marlowe and D. M. Wolk mo
- Page 1056:
518 E. M. Marlowe and D. M. Wolk Mo
- Page 1060:
520 E. M. Marlowe and D. M. Wolk Ha
- Page 1064:
522 E. M. Marlowe and D. M. Wolk Sa
- Page 1068:
Index A acetate utilization, 100 Ac
- Page 1072:
Index 527 rapid antigen tests, 27-2
- Page 1076:
Index 529 flow cytometric immunoass
- Page 1080:
Index 531 Human T-Lymphotropic Viru
- Page 1084:
Index 533 MLEE. See multilocus enzy
- Page 1088:
Index 535 PNA. See peptide-nucleic
- Page 1092:
Index 537 Roseomonas, 328-329 rotav
- Page 1096:
Index 539 T TaqMan probes, 293-296